With a median age of 61 years (17-93), 60.9% (42/69) of patients were male, and most of the pathologic subtypes were AITL (55.1%), ALK-ALCL (11.6%), PTCL-NOS (21.7%). Here, ALK is linked to angioimmunoblastic T-cell lymphoma.